Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2017-09, Vol.28, p.v162-v162
Hauptverfasser: Bridgewater, J., Pugh, S., Whitehead, A., Stanton, L., Eminton, Z., Mellor, J., Allen, A., Finch-Jones, M., Falk, S., Iveson, T., Rees, M., Valle, J.W., Hornbuckle, J., Hickish, T., Cunningham, D., Maughan, T., Garden, J., Griffiths, G., Primrose, J.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page v162
container_issue
container_start_page v162
container_title Annals of oncology
container_volume 28
creator Bridgewater, J.
Pugh, S.
Whitehead, A.
Stanton, L.
Eminton, Z.
Mellor, J.
Allen, A.
Finch-Jones, M.
Falk, S.
Iveson, T.
Rees, M.
Valle, J.W.
Hornbuckle, J.
Hickish, T.
Cunningham, D.
Maughan, T.
Garden, J.
Griffiths, G.
Primrose, J.
description
doi_str_mv 10.1093/annonc/mdx393.010
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx393_010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753420389705</els_id><sourcerecordid>S0923753420389705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1850-32a357a9108081c9d8b91e45120b00c23dbead44da25cfd5dc9a14de6ac2eeb83</originalsourceid><addsrcrecordid>eNp9kc9u2zAMxoVhA5p1fYDedEwOTiXLTq3uNATZWiBZiv45G7TEICpky5CUtHnKvlLluecBAigS_H0k-BFyydmcMymuoOtcp65a_SakmDPOvpAJLxcyq1jBv5IJk7nIrktRnJHvIbwwxhYylxPyfo_euB49RHNEqvbYurhPaX-irybuqfP_ojtEqjAe3kwLDTUd7ROAXQx02scwG3s9BlQRGpuEnHV-SCy1SdjTFiOE9Ewilg_rzeyGbiAePFLowJ6GuttRl1rBWhoO_miOCZ5uH2fDuLQT_YuvdHW_XVIPnXatCajTnC56Z236Rm_A_iDfdmADXnzGc_L8e_W0vM3W2z93y1_rTPGqZJnIQZTXIDmrWMWV1FUjORYlz1nDmMqFbhB0UWjIS7XTpVYSeKFxASpHbCpxTvioq7wLweOu7n06jT_VnNWDI_XoSD06UidHEvNzZDAtdjTo66DSDRVqM5yq1s78h_4AXwicEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bridgewater, J. ; Pugh, S. ; Whitehead, A. ; Stanton, L. ; Eminton, Z. ; Mellor, J. ; Allen, A. ; Finch-Jones, M. ; Falk, S. ; Iveson, T. ; Rees, M. ; Valle, J.W. ; Hornbuckle, J. ; Hickish, T. ; Cunningham, D. ; Maughan, T. ; Garden, J. ; Griffiths, G. ; Primrose, J.</creator><creatorcontrib>Bridgewater, J. ; Pugh, S. ; Whitehead, A. ; Stanton, L. ; Eminton, Z. ; Mellor, J. ; Allen, A. ; Finch-Jones, M. ; Falk, S. ; Iveson, T. ; Rees, M. ; Valle, J.W. ; Hornbuckle, J. ; Hickish, T. ; Cunningham, D. ; Maughan, T. ; Garden, J. ; Griffiths, G. ; Primrose, J.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx393.010</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-09, Vol.28, p.v162-v162</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1850-32a357a9108081c9d8b91e45120b00c23dbead44da25cfd5dc9a14de6ac2eeb83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Bridgewater, J.</creatorcontrib><creatorcontrib>Pugh, S.</creatorcontrib><creatorcontrib>Whitehead, A.</creatorcontrib><creatorcontrib>Stanton, L.</creatorcontrib><creatorcontrib>Eminton, Z.</creatorcontrib><creatorcontrib>Mellor, J.</creatorcontrib><creatorcontrib>Allen, A.</creatorcontrib><creatorcontrib>Finch-Jones, M.</creatorcontrib><creatorcontrib>Falk, S.</creatorcontrib><creatorcontrib>Iveson, T.</creatorcontrib><creatorcontrib>Rees, M.</creatorcontrib><creatorcontrib>Valle, J.W.</creatorcontrib><creatorcontrib>Hornbuckle, J.</creatorcontrib><creatorcontrib>Hickish, T.</creatorcontrib><creatorcontrib>Cunningham, D.</creatorcontrib><creatorcontrib>Maughan, T.</creatorcontrib><creatorcontrib>Garden, J.</creatorcontrib><creatorcontrib>Griffiths, G.</creatorcontrib><creatorcontrib>Primrose, J.</creatorcontrib><title>Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u2zAMxoVhA5p1fYDedEwOTiXLTq3uNATZWiBZiv45G7TEICpky5CUtHnKvlLluecBAigS_H0k-BFyydmcMymuoOtcp65a_SakmDPOvpAJLxcyq1jBv5IJk7nIrktRnJHvIbwwxhYylxPyfo_euB49RHNEqvbYurhPaX-irybuqfP_ojtEqjAe3kwLDTUd7ROAXQx02scwG3s9BlQRGpuEnHV-SCy1SdjTFiOE9Ewilg_rzeyGbiAePFLowJ6GuttRl1rBWhoO_miOCZ5uH2fDuLQT_YuvdHW_XVIPnXatCajTnC56Z236Rm_A_iDfdmADXnzGc_L8e_W0vM3W2z93y1_rTPGqZJnIQZTXIDmrWMWV1FUjORYlz1nDmMqFbhB0UWjIS7XTpVYSeKFxASpHbCpxTvioq7wLweOu7n06jT_VnNWDI_XoSD06UidHEvNzZDAtdjTo66DSDRVqM5yq1s78h_4AXwicEA</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Bridgewater, J.</creator><creator>Pugh, S.</creator><creator>Whitehead, A.</creator><creator>Stanton, L.</creator><creator>Eminton, Z.</creator><creator>Mellor, J.</creator><creator>Allen, A.</creator><creator>Finch-Jones, M.</creator><creator>Falk, S.</creator><creator>Iveson, T.</creator><creator>Rees, M.</creator><creator>Valle, J.W.</creator><creator>Hornbuckle, J.</creator><creator>Hickish, T.</creator><creator>Cunningham, D.</creator><creator>Maughan, T.</creator><creator>Garden, J.</creator><creator>Griffiths, G.</creator><creator>Primrose, J.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial</title><author>Bridgewater, J. ; Pugh, S. ; Whitehead, A. ; Stanton, L. ; Eminton, Z. ; Mellor, J. ; Allen, A. ; Finch-Jones, M. ; Falk, S. ; Iveson, T. ; Rees, M. ; Valle, J.W. ; Hornbuckle, J. ; Hickish, T. ; Cunningham, D. ; Maughan, T. ; Garden, J. ; Griffiths, G. ; Primrose, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1850-32a357a9108081c9d8b91e45120b00c23dbead44da25cfd5dc9a14de6ac2eeb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bridgewater, J.</creatorcontrib><creatorcontrib>Pugh, S.</creatorcontrib><creatorcontrib>Whitehead, A.</creatorcontrib><creatorcontrib>Stanton, L.</creatorcontrib><creatorcontrib>Eminton, Z.</creatorcontrib><creatorcontrib>Mellor, J.</creatorcontrib><creatorcontrib>Allen, A.</creatorcontrib><creatorcontrib>Finch-Jones, M.</creatorcontrib><creatorcontrib>Falk, S.</creatorcontrib><creatorcontrib>Iveson, T.</creatorcontrib><creatorcontrib>Rees, M.</creatorcontrib><creatorcontrib>Valle, J.W.</creatorcontrib><creatorcontrib>Hornbuckle, J.</creatorcontrib><creatorcontrib>Hickish, T.</creatorcontrib><creatorcontrib>Cunningham, D.</creatorcontrib><creatorcontrib>Maughan, T.</creatorcontrib><creatorcontrib>Garden, J.</creatorcontrib><creatorcontrib>Griffiths, G.</creatorcontrib><creatorcontrib>Primrose, J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bridgewater, J.</au><au>Pugh, S.</au><au>Whitehead, A.</au><au>Stanton, L.</au><au>Eminton, Z.</au><au>Mellor, J.</au><au>Allen, A.</au><au>Finch-Jones, M.</au><au>Falk, S.</au><au>Iveson, T.</au><au>Rees, M.</au><au>Valle, J.W.</au><au>Hornbuckle, J.</au><au>Hickish, T.</au><au>Cunningham, D.</au><au>Maughan, T.</au><au>Garden, J.</au><au>Griffiths, G.</au><au>Primrose, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v162</spage><epage>v162</epage><pages>v162-v162</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdx393.010</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2017-09, Vol.28, p.v162-v162
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdx393_010
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A51%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perioperative%20chemotherapy%20with%20or%20without%20cetuximab%20in%20patients%20(pts)%20with%20resectable%20colorectal%20liver%20metastasis%20(CRLM):%20Mature%20analysis%20of%20overall%20survival%20(OS)%20in%20the%20New%20EPOC%20randomised%20controlled%20trial&rft.jtitle=Annals%20of%20oncology&rft.au=Bridgewater,%20J.&rft.date=2017-09&rft.volume=28&rft.spage=v162&rft.epage=v162&rft.pages=v162-v162&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx393.010&rft_dat=%3Celsevier_cross%3ES0923753420389705%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753420389705&rfr_iscdi=true